Efficacy of Favipiravir in treatment of mild & moderate COVID-19 infection in Nepal: a multi-center, randomized, open-labelled, phase III clinical trial

Autor: Adhikari, P., Koirala, J., Shrestha, A., Bista, N., Maleku, K., Das, J., Bhandari, K., Adhikari, N., Rawal, A., Pandit, K., Gyawali, P., Pant, S.
Zdroj: In International Journal of Infectious Diseases March 2022 116 Supplement:S45-S46
Databáze: ScienceDirect